Irina Gitlin, PhD, is a project manager for a drug development program in the laboratory of John V. Fahy; the project aims to bring to the clinic a novel mucolytic therapeutic agent to treat lung disease. Previously Irina was a Senior Program Manager in the Catalyst group at the Clinical and Translational Science Institute (CTSI) at UCSF, where she was responsible for management of campus-wide programs to facilitate translation of academic discoveries into valuable biomedical products. Prior to joining CTSI, Irina was a senior scientist at Arsenal Medical, an early stage medical device company in Boston area that specializes in bioresorbable polymer technologies. Her various roles in the company included leading the company's efforts in securing grants for technology development, managing the IP portfolio, and studying interactions of polymeric materials with cells and tissues. Irina earned her Ph.D. from the laboratory of George M. Whitesides in the Chemistry Department at Harvard University, working in the fields of protein biophysics and microfluidics.